317 related articles for article (PubMed ID: 17164726)
1. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Luminex donor-specific crossmatches.
Billen EV; Voorter CE; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2008 Jun; 71(6):507-13. PubMed ID: 18380779
[TBL] [Abstract][Full Text] [Related]
4. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
Vaidya S
Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587
[TBL] [Abstract][Full Text] [Related]
6. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
[TBL] [Abstract][Full Text] [Related]
7. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
8. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
9. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
11. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells.
Alheim M; Johansson SM; Hauzenberger D; Grufman P; Holgersson J
Tissue Antigens; 2010 Mar; 75(3):269-77. PubMed ID: 20070600
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
[TBL] [Abstract][Full Text] [Related]
13. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
14. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
16. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
[TBL] [Abstract][Full Text] [Related]
17. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
18. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
[TBL] [Abstract][Full Text] [Related]
19. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
[TBL] [Abstract][Full Text] [Related]
20. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
